These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 12740447

  • 1. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
    Mitchell JE, Gosnell BA, Roerig JL, de Zwaan M, Wonderlich SA, Crosby RD, Burgard MA, Wambach BN.
    Obes Res; 2003 May; 11(5):599-602. PubMed ID: 12740447
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC, Bacaltchuk J, Sichieri R, Claudino AM, Godoy-Matos A, Morgan C, Zanella MT, Coutinho W.
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [Abstract] [Full Text] [Related]

  • 3. The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women.
    Halford JC, Boyland EJ, Cooper SJ, Dovey TM, Huda MS, Dourish CT, Dawson GR, Wilding JP.
    J Psychopharmacol; 2010 Jan; 24(1):99-109. PubMed ID: 18755818
    [Abstract] [Full Text] [Related]

  • 4. Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder.
    Bauer C, Fischer A, Keller U.
    Diabetes Obes Metab; 2006 May; 8(3):289-95. PubMed ID: 16634988
    [Abstract] [Full Text] [Related]

  • 5. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.
    Tallett AJ, Blundell JE, Rodgers RJ.
    Behav Brain Res; 2009 Mar 17; 198(2):359-65. PubMed ID: 19061919
    [Abstract] [Full Text] [Related]

  • 6. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.
    Clin Ther; 2004 Sep 17; 26(9):1427-35. PubMed ID: 15531005
    [Abstract] [Full Text] [Related]

  • 7. Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study.
    Di Francesco V, Sacco T, Zamboni M, Bissoli L, Zoico E, Mazzali G, Minniti A, Salanitri T, Cancelli F, Bosello O.
    Ann Nutr Metab; 2007 Sep 17; 51(1):75-81. PubMed ID: 17356258
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.
    Wilfley DE, Crow SJ, Hudson JI, Mitchell JE, Berkowitz RI, Blakesley V, Walsh BT, Sibutramine Binge Eating Disorder Research Group.
    Am J Psychiatry; 2008 Jan 17; 165(1):51-8. PubMed ID: 18056225
    [Abstract] [Full Text] [Related]

  • 9. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K, Finer N, Rössner S.
    Diabetes Obes Metab; 2008 Jun 17; 10(6):498-505. PubMed ID: 17593239
    [Abstract] [Full Text] [Related]

  • 10. Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome.
    Barkeling B, Elfhag K, Rooth P, Rössner S.
    Int J Obes Relat Metab Disord; 2003 Jun 17; 27(6):693-700. PubMed ID: 12833113
    [Abstract] [Full Text] [Related]

  • 11. Modalities of the food intake-reducing effect of sibutramine in humans.
    Chapelot D, Marmonier C, Thomas F, Hanotin C.
    Physiol Behav; 2000 Jan 17; 68(3):299-308. PubMed ID: 10716539
    [Abstract] [Full Text] [Related]

  • 12. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.
    Devlin MJ, Goldfein JA, Petkova E, Jiang H, Raizman PS, Wolk S, Mayer L, Carino J, Bellace D, Kamenetz C, Dobrow I, Walsh BT.
    Obes Res; 2005 Jun 17; 13(6):1077-88. PubMed ID: 15976151
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of sibutramine intake on resting and exercise physiological responses.
    Rotstein A, Inbar O, Vaisman N.
    Ann Nutr Metab; 2008 Jun 17; 52(1):17-23. PubMed ID: 18230966
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study.
    Milano W, Petrella C, Casella A, Capasso A, Carrino S, Milano L.
    Adv Ther; 2005 Jun 17; 22(1):25-31. PubMed ID: 15943219
    [Abstract] [Full Text] [Related]

  • 18. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
    Hainer V, Kunesova M, Bellisle F, Hill M, Braunerova R, Wagenknecht M.
    Int J Obes (Lond); 2005 Feb 17; 29(2):208-16. PubMed ID: 15583700
    [Abstract] [Full Text] [Related]

  • 19. Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial.
    Svendsen M, Rissanen A, Richelsen B, Rössner S, Hansson F, Tonstad S.
    Obesity (Silver Spring); 2008 Feb 17; 16(2):327-33. PubMed ID: 18239640
    [Abstract] [Full Text] [Related]

  • 20. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM, Balance Study Group.
    Eur J Clin Nutr; 2005 Aug 17; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.